BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31203662)

  • 1. Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it.
    Verma H; Singh Bahia M; Choudhary S; Kumar Singh P; Silakari O
    Drug Metab Rev; 2019 May; 51(2):196-223. PubMed ID: 31203662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review.
    Raju B; Choudhary S; Narendra G; Verma H; Silakari O
    Drug Metab Rev; 2021 Feb; 53(1):45-75. PubMed ID: 33535824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review.
    Korashy HM; Elbekai RH; El-Kadi AO
    Xenobiotica; 2004 Jan; 34(1):1-29. PubMed ID: 14742134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
    Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
    Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Drug-metabolizing Enzymes in Cancer and Cancer Therapy.
    Feng S; Li A; Zheng YC; Liu HM
    Curr Drug Metab; 2020; 21(1):67-76. PubMed ID: 31902352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
    Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
    Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical role of genetic polymorphisms in drug-metabolizing enzymes.
    Tomalik-Scharte D; Lazar A; Fuhr U; Kirchheiner J
    Pharmacogenomics J; 2008 Feb; 8(1):4-15. PubMed ID: 17549068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of liver diseases on drug-metabolizing enzymes: implications for drug fate alterations and nano-therapeutic openings.
    Lu L; Shi J; Li Q; Peng X; Dong L; Li Y; Dai P; Wang Y; Guo E; Zhou F; Liu Z
    Curr Med Chem; 2014; 21(22):2522-41. PubMed ID: 24358976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer.
    Wang J; Yu L; Jiang H; Zheng X; Zeng S
    Drug Metab Dispos; 2020 Sep; 48(9):759-768. PubMed ID: 32601104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-metabolizing enzymes: role in drug resistance in cancer.
    Kaur G; Gupta SK; Singh P; Ali V; Kumar V; Verma M
    Clin Transl Oncol; 2020 Oct; 22(10):1667-1680. PubMed ID: 32170639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacogenetics of drug metabolizing enzymes in the Lebanese population.
    Ossaily S; Zgheib NK
    Drug Metabol Drug Interact; 2014; 29(2):81-90. PubMed ID: 24413215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INTEDE: interactome of drug-metabolizing enzymes.
    Yin J; Li F; Zhou Y; Mou M; Lu Y; Chen K; Xue J; Luo Y; Fu J; He X; Gao J; Zeng S; Yu L; Zhu F
    Nucleic Acids Res; 2021 Jan; 49(D1):D1233-D1243. PubMed ID: 33045737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNA in drug metabolism and transport.
    Yu AM
    Curr Drug Metab; 2007 Oct; 8(7):700-8. PubMed ID: 17979658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives.
    Jin Q; Wu J; Wu Y; Li H; Finel M; Wang D; Ge G
    Acta Pharm Sin B; 2022 Mar; 12(3):1068-1099. PubMed ID: 35530147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.
    CONNEY AH; DAVISON C; GASTEL R; BURNS JJ
    J Pharmacol Exp Ther; 1960 Sep; 130():1-8. PubMed ID: 13811549
    [No Abstract]   [Full Text] [Related]  

  • 19. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.
    van Groen BD; Nicolaï J; Kuik AC; Van Cruchten S; van Peer E; Smits A; Schmidt S; de Wildt SN; Allegaert K; De Schaepdrijver L; Annaert P; Badée J
    Pharmacol Rev; 2021 Apr; 73(2):597-678. PubMed ID: 33608409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics-small molecule drug interactions.
    Mallick P; Taneja G; Moorthy B; Ghose R
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):605-616. PubMed ID: 28537216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.